[February 14, 2013] |
|
US Patent Innovations, LLC Completes Plasma Technology Research Agreement with The George Washington University
TAKOMA PARK, Md. --(Business Wire)--
US Patent Innovations, LLC (USPI), a private biomedical devices company,
announced today that it signed a five-year research agreement with The
George Washington University of Washington, D.C. (GWU) on February 6,
2013. Under the agreement, USPI will provide funding for collaborative
research exploring the mechanisms of plasma cutting and coagulation of
biological tissue, with the goal of developing a set of devices
utilizing both Cold and Hybrid Plasma applications in surgery. The
research project will be led by principal investigator Dr. Michael
Keidar of GWU's Mechanical and Aerospace Engineering epartment, and
co-investigator Jerome Canady, M.D., Director of Research at Plasma
Medicine Life Science, LLC, a new subsidiary of USPI.
The new plasma devices will complement the Canady Plasma® and Canady
Vieira Hybrid PlasmaTM lines of products already in
distribution by USPI's subsidiary, US Medical Innovations, LLC (USMI)
and by WEM Equipamentos Electronicos LTDA (Ribeirao Preto - Sao Paulo,
Brazil). These devices utilize a breakthrough approach to
electrosurgery, known as "Hybrid Plasma Technology," permitting surgery
with virtually no blood loss and without the use of a traditional
scalpel blade.
Commenting on the agreement, Dr. Canady said, "This exciting development
enhances our recent Technology Transfer Agreement with GWU and Johns
Hopkins University. The resulting research surrounding Cold Plasma
devices for the selective eradication of cancer cells, together with our
Hybrid Plasma Technology development efforts with WEM, will provide a
platform for new product development that will impact the manner in
which surgery as well as cancer treatments are performed in the future."
[ Back To TMCnet.com's Homepage ]
|